HOLLEY COKER: Open Payments
NPI 1427820802 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,977 in 102 payments from 23 companies in 2025. Trend: 2023 $324 · 2024 $2,291 · 2025 $1,977
Food & beverage: $1,878Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $425 |
| AstraZeneca Pharmaceuticals LP | 16 | $289 |
| Novartis Pharmaceuticals Corporation | 9 | $166 |
| Janssen Biotech, Inc. | 7 | $158 |
| Incyte Corporation | 1 | $99 |
| Eisai Inc. | 4 | $86 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Merck Sharp & Dohme LLC | 4 | $66 |
Products named: EPKINLY, IMFINZI, ENHERTU, KISQALI, RYBREVANT, Lenvima, Nubeqa, VENCLEXTA.
Industry payments across AR — which companies pay providers there.
